ticlopidine has been researched along with Acquired Nephrogenic Diabetes Insipidus in 1 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, Y | 1 |
| Peti-Peterdi, J | 1 |
| Müller, CE | 1 |
| Carlson, NG | 1 |
| Baqi, Y | 1 |
| Strasburg, DL | 1 |
| Heiney, KM | 1 |
| Villanueva, K | 1 |
| Kohan, DE | 1 |
| Kishore, BK | 1 |
1 other study available for ticlopidine and Acquired Nephrogenic Diabetes Insipidus
| Article | Year |
|---|---|
P2Y12 Receptor Localizes in the Renal Collecting Duct and Its Blockade Augments Arginine Vasopressin Action and Alleviates Nephrogenic Diabetes Insipidus.
Topics: Animals; Aquaporin 2; Arginine Vasopressin; Clopidogrel; Deamino Arginine Vasopressin; Diabetes Insi | 2015 |